Annual report pursuant to Section 13 and 15(d)

Capital Stock (Tables)

v3.19.2
Capital Stock (Tables)
12 Months Ended
Mar. 31, 2019
Fair Value Disclosures [Abstract]  
Schedule of Black Scholes option pricing model

Assumption:

  Pre-reset     Post-reset  
Market price per share   $ 1.17     $ 1.17  
Exercise price per share   $ 1.82     $ 0.001  
Risk-free interest rate     2.09 %     2.09 %
Remaining contractual term in years     4.73       4.73  
Volatility     97.8 %     97.8 %
Dividend rate     0.0 %     0.0 %
                 
Number of warrant shares     503,641       503,641  
Fair value per share   $ 0.77     $ 1.17  
Schedule of outstanding warrants to purchase shares
Exercise Price    Expiration   Warrants Outstanding at   Warrants Exercisable at
per Share   Date   March 31, 2019   March 31, 2019
             
$ 1.50       11/30/2021 to 12/13/2022       14,335,200       13,857,200  
$ 1.59       2/28/2022       292,000       —    
$ 1.69       2/28/2022       12,000       —    
$ 1.70       10/5/2022       182,434       182,434  
$ 1.75       2/28/2022       23,800       —    
$ 1.80       10/10/2022       115,385       115,385  
$ 1.82       3/7/2023       1,388,931       1,388,931  
$ 2.00       4/30/2021       523,573       523,573  
$ 2.20       10/19/2022       106,383       106,383  
$ 2.24       10/16/2022       16,737       16,737  
$ 3.51       12/31/2021       50,000       50,000  
$ 4.50       9/26/2019       25,000       25,000  
$ 5.30       5/16/2021       2,705,883       2,705,883  
$ 6.00       9/26/2019 to 11/30/2019       97,750       97,750  
$ 7.00       1/11/2020 to 3/3/2023       1,262,878       1,262,878  
$ 8.00       3/25/2021       185,000       185,000  
$ 10.00       1/11/2020       20,000       20,000  
$ 20.00       9/15/2019       110,448       110,448  
                  21,453,402       20,647,602  
Schedule of reserved shares of common stock for future issuance
Upon exchange of all shares of Series A Preferred currently issued and outstanding (1)     750,000  
Upon exchange of all shares of Series B Preferred currently issued and outstanding (2)     5,096,738  
Upon exchange of all shares of Series C Preferred currently issued and outstanding (3)     2,318,012  
Pursuant to warrants to purchase common stock:        
    Subject to outstanding warrants     21,453,402  
Pursuant to stock incentive plan:        
   Subject to outstanding options under the Amended and Restated 2016 Stock Incentive  Plan     6,626,088  
    Available for future grants under the Amended and Restated 2016 Stock Incentive Plan     2,607,162  
      9,233,250  
Total     38,851,402  
(1) Assumes exchange under the terms of the October 11, 2012 Note Exchange and Purchase Agreement        
(2) Assumes exchange under the terms of the Certificate of Designation of the Relative Rights and Preferences of the Series B 10% Convertible Preferred Stock, effective May 5, 2015; includes 3,936,498 shares of common stock issuable in payment of dividends on Series B Preferred upon conversion        
(3) Assumes exchange under the terms of the Certificate of Designation of the Relative Rights and Preferences of the Series C Convertible Preferred Stock, effective January 25, 2016